inhibits lipogenesis in adipocytes both directly by downregulating fatty acid synthase and indirectly by reducing the sensitivity of adipocytes to insulin action
Multiple companies have already filed or signalled applications, and domestic manufacturing plans are being publicly discussed
If missed doses are happening often: Talk with your provider
Your care team reviews your labs, symptoms, and treatment response, provides coaching to improve outcomes, and offers guidance you can share with your prescribing clinician regarding dosing, tolerance, and long-term strategy.
Employee health insurance in Norwell, Duxbury, Marshfield, Plymouth, Cohasset, Scituate and Hanover does not currently cover GLP-1s for non-diabetic patients, and Kingston and Hingham and will cease covering the drugs for non-diabetic patients in July